Aaron Sato | Chief Scientific Officer of Twist Biopharma
Twist Bioscience

Aaron Sato, Chief Scientific Officer of Twist Biopharma, Twist Bioscience

Aaron is CSO of Twist Bioscience and is a proven biologics leader adept at managing teams to discover novel first-in-class antibody therapeutics.  Prior to Twist, he served as Chief Scientific Officer of LakePharma, leading the California Antibody Center, which discovers novel antibody therapeutics for its clients. He also oversaw all discovery research functions both as Vice President of Protein Sciences at Surrozen, and previously, as Vice President of Research at Sutro Biopharma, Inc. He also held director level positions at both Oncomed and Dyax Corp.

Appearances:



Festival of Biologics Day 1 @ 16:50

Writing the Future of Biologics with Synthetic DNA and Machine Learning

Utilizing its proprietary DNA technology to write synthetic libraries, Twist Biopharma provides end-to-end antibody discovery libraries including both (1) highly diverse synthetic naïve antibody phage display libraries and (2) target class specific antibody phage display libraries against difficult-to-drug targets.  In this talk, Aaron Sato, CSO, will present on how Twist uses our libraries coupled with Machine Learning to discover 1) antibody sequences from NGS sequencing of our successive panning rounds and 2) optimize existing leads derived from traditional screening.

last published: 01/Jul/22 16:05 GMT

back to speakers